Histone cluster 1 H2AL Inhibitors belong to a specialized class of chemical compounds designed to selectively impede the activity of histone cluster 1, with a specific focus on the H2AL subtype. Histones play a pivotal role in the organization of DNA within the nucleus, forming nucleosomes that provide the structural foundation for chromatin. The designation H2AL denotes a variant of histone H2A, one of the core histones essential for nucleosome assembly. The H2A family of histones is integral to the regulation of gene expression and the modulation of chromatin architecture. Inhibitors tailored for Histone cluster 1 H2AL are intricately crafted to interact with specific regions of this histone variant, potentially influencing its binding to DNA and other proteins, thereby modulating chromatin dynamics.
The development of Histone cluster 1 H2AL Inhibitors requires a detailed understanding of the structural characteristics of histone H2AL and its specific role within chromatin organization. These inhibitors are engineered for specificity, aiming to selectively bind to key regions of Histone cluster 1 H2AL and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can explore the consequences of inhibiting this particular histone variant, providing valuable insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H2AL, contributes significantly to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat is a histone deacetylase inhibitor, altering chromatin structure and potentially affecting the acetylation status of histones, including H2AL. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 inhibits lysine demethylase, potentially influencing histone demethylation and the transcriptional regulation of genes, including H2AL. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H2AL. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat inhibits histone deacetylase, altering chromatin structure and potentially affecting the acetylation status of histones, including H2AL. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 targets the methyltransferase activity of histone methyltransferase, possibly impacting the methylation status and expression of H2AL. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a potent histone deacetylase inhibitor, influencing gene expression by maintaining acetylation levels on histones, including H2AL. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $90.00 $238.00 $300.00 | ||
GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including Histone cluster 1 H2AL. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor, disrupting interactions between bromodomain proteins and acetylated histones, potentially influencing gene expression, including H2AL. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H2AL. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2AL. | ||||||